Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Experimental Biology and Medicine (Maywood, N.J.)|July 26, 2012
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infectionLaura Vidalino, Andrea Doria, Santina M Quarta, et al.
Oncotarget|October 31, 2015
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survivalValentina Trimarco, Elisa Ave, Monica Facco, et al.
British Journal of Haematology|March 11, 2014
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazoleFederica Frezzato, Valentina Trimarco, Veronica Martini, et al.
Leukemia|October 25, 2018
Mitochondrial apoptosis is induced by Alkoxy phenyl-1-propanone derivatives through PP2A-mediated dephosphorylation of Bad and Foxo3A in CLLMario Angelo Pagano, Elena Tibaldi, Pierfrancesco Molino, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 3, 2015
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic LeukemiaAndrea Visentin, Monica Facco, Federica Frezzato, et al.
British Journal of Haematology|April 19, 2017
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cellsVeronica Martini, Cristina Gattazzo, Federica Frezzato, et al.
Cancers|November 13, 2021
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic LeukemiaFederica Frezzato, Andrea Visentin, Filippo Severin, et al.
Cell Death & Disease|February 15, 2024
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemiaGioia Boncompagni, Vanessa Tatangelo, Ludovica Lopresti, et al.
Frontiers in Immunology|May 29, 2024
Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapyEdoardo Ruggeri, Federica Frezzato, Nayla Mouawad, et al.
Haematologica|March 2, 2019
p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscapeLaura Patrussi, Nagaja Capitani, Cristina Ulivieri, et al.
Pageof 6